D. Thompson, S. P. Hrrison, S. W. Evans and J. T. Whicher, “Insulin Modulation of Acute Phase Protein Production in a Human Hepatoma Cell Line,” Cytokine, Vol. 3, No. 6, 1991, pp. 619-626. doi:10.1016/1043-4666(91)90489-Z

has been cited by the following article:

• TITLE: Bitter Melon (Momordica Charantia) Reduces Serum Sialic Acid in Type2 Diabetics: Evidence to Delay the Process of Atherosclerosis

  AUTHORS: Inayat Ur Rahman, Mohammad Bashir, Mohammad Salman, Mohammad Idrees, Mohammad Iqbal Khan

  KEYWORDS: Sialic Acid, Type2 Diabetes Mellitus, Bitter Melon, Cardiovascular Disease

  JOURNAL NAME: Chinese Medicine, Vol.2 No.4, December 8, 2011

  ABSTRACT: More than 1000 herbal products have been used by diverse cultures of the world to treat hyperglycemia and among them bitter melon (Momordica charantia) is one of the most popular herbal resource. The beneficial effects of bitter melon is not limited to hypoglycaemia only, but it also ameliorates diet induced obesity, insulin resistance and exhibit cardioprotective effects. The present study attempts to investigate the effect of bitter melon fruit juice on a newly investigated risk factor, sialic acid in type2 diabetics. A total of 40 type2 diabetic patients, divided into group A (n = 20) and group B (n = 20) were investigated during the present study. The patients of group A were following bitter melon fruit juice treatment along with diet control, whereas the patients of group B were on diet control only. Serum sialic acid (SSA) decreased in group A from 66.20 ± 2.30 mg/dl to 63.50 ± 2.10 mg/dl (